Repository logo
 

Single-cell RNA sequencing reveals sex differences in the subcellular composition and associated gene-regulatory network activity of human carotid plaques.

Published version
Peer-reviewed

Repository DOI


Change log

Authors

Abstract

Carotid stenosis causes ischemic stroke in both sexes, but the clinical presentation and plaque characteristics differ. Here we run deep single-cell sequencing of 7,690 human carotid plaque cells from male and female patients. While we found no sex differences in major cell types, we identified a predominance of the osteogenic phenotype in smooth muscle cells, immunomodulating macrophages (MPs) and endothelial cells (ECs) undergoing endothelial-to-mesenchymal transition in females. In males, we found smooth muscle cells with the chondrocytic phenotype, MPs involved in tissue remodeling and ECs with angiogenic activity. Sex-biased subcellular clusters were integrated with tissue-specific gene-regulatory networks (GRNs) from the Stockholm-Tartu Atherosclerosis Reverse Network Engineering Task study. We identified GRN195 involved in angiogenesis and T cell-mediated cytotoxicity in male ECs, while in females, we found GRN33 and GRN122 related to TREM2-/TREM1+ MPs and endothelial-to-mesenchymal transition. The impact of GRN195 on EC proliferation in males was functionally validated, providing evidence for potential therapy targets for atherosclerosis that are sex specific.

Description

Acknowledgements: J.L.M.B. acknowledges support from the Swedish Research Council (2018-02529 and 2022-00734), the Swedish Heart Lung Foundation (2017-0265 and 2020-0207), the Leducq Foundation AtheroGen (22CVD04) and PlaqOmics(18CVD02) consortia, the National Institute of Health–National Heart Lung Blood Institute (NIH/NHLBI; R01HL164577, R01HL148167, R01HL148239, R01HL166428 and R01HL168174), the American Heart Association Transformational Project Award 19TPA34910021 and the CMD AMP fNIH program. P.S. was supported by the Finnish Foundation for Cardiovascular Research. T.O. was supported by the Research Council of Finland, Competitive Funding to Strengthen University Research Profiles, 7th Call, profiling measure TransMed (352968). Personal grants to I.S. were received from the Finnish Cultural Foundation and the Finnish Foundation for Cardiovascular Research. J.P.L. was supported by the Research Council of Finland (328835) and GeneCellNano Flagship Program 337120. M.U.K. acknowledges support from the Research Council of Finland (333021), the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation and the European Union (ERC, SECRET, 101125115 to M.U.K.). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.L.M.B. and M.U.K. acknowledge the European Union’s Horizon Europe (European Innovation Council) program under grant agreement number 101115381. J.C.K. acknowledges research support from the NIH (R01HL148167 and R01HG012773), New South Wales health grant RG194194, the Bourne Foundation, Snow Medical and Agilent. C.L.M. acknowledges support from NIH (R01HL148239 and R01HL164577), the Leducq Foundation PlaqOmics (18CVD02) network, Single-Cell Data Insights award from the Chan Zuckerberg Initiative, LLC, and Silicon Valley Community Foundation. We wish to acknowledge the Single Cell Core Facility of Flemingsberg Campus (SICOF) at the Department of Medicine, Huddinge, Karolinska Institute, Stockholm, and the UEF Cell and Tissue Imaging Unit and the Single Cell Genomics Core at the University of Eastern Finland (Biocenter Kuopio, Biocenter Finland) for their valuable infrastructure support. We acknowledge M. Lukkari, R. Kärnä, M. Kiema and M. Hosiasluoma at A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, for technical assistance.


Funder: research support from the NIH (R01HL148167, R01HG012773), New South Wales health grant RG194194, the Bourne Foundation, Snow Medical and Agilent


Funder: Sydäntutkimussäätiö (Finnish Foundation for Cardiovascular Research); doi: https://doi.org/10.13039/501100005633


Funder: Sigrid Juséliuksen Säätiö (Sigrid Jusélius Foundation); doi: https://doi.org/10.13039/501100006306


Funder: Research Council of Finland, Competitive Funding to Strengthen University Research Profiles, 7th Call, profiling measure TransMed, (352968)


Funder: The Research Council of Finland (328835), and GeneCellNano Flagship Program 337120

Keywords

Journal Title

Nat Cardiovasc Res

Conference Name

Journal ISSN

2731-0590
2731-0590

Volume Title

4

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
American Heart Association (American Heart Association, Inc.) (19TPA34910021)
Fondation Leducq (AtheroGen (22CVD04) and PlaqOmics(18CVD02), PlaqOmics (18CVD02))